Merck Sharp & Dohme LLC has divulged NLRP3 inflammasome inhibitors reported to be useful for the treatment of atherosclerosis, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...

THE COURT of Tax Appeals (CTA) has ordered the Bureau of Internal Revenue (BIR) to refund P14.59 million to the local branch of United States-based pharmaceutical company Merck Sharp & Dohme (MSD), ...

Case brought by a Tipperary farmer against Merck Sharp and Dohme Chemicals (MSD) is dismissed by the High Court. Report shows the Hanrahan family arriving at court. Shots of Hanrahan farm.

Merck, Sharp, and Dohme (MSD)’s Keytruda (pembrolizumab) will be available for those with previously untreated metastatic nonsquamous non-small cell lung cancer (NSCLC), where tumours have ...

Merck Sharp & Dohme LLC has patented new 5,6 saturated bicyclic heterocyles acting as NLRP3 inflammasome inhibitors potentially useful for the treatment of atherosclerosis, metabolic ...